Advertisement · 728 × 90
#
Hashtag
#ILUMYA
Advertisement · 728 × 90
Preview
Sun Pharma Showcases Major Research Advancements at 2026 AAD Annual Meeting At the 2026 AAD Annual Meeting, Sun Pharma presents 14 abstracts, showcasing advancements in the treatment of alopecia areata, psoriasis, and acne. The company emphasizes patient-centered care through meaningful scientific data.

Sun Pharma Showcases Major Research Advancements at 2026 AAD Annual Meeting #India #Mumbai #ILUMYA #Sun_Pharma #LEQSELVI

0 0 0 0
Preview
Sun Pharma's ILUMYA Receives FDA Review for Psoriatic Arthritis Treatment Expansion Sun Pharma has announced that the FDA has accepted its application for ILUMYA, aiming to expand treatment options for adults with psoriatic arthritis, adding to its existing psoriasis indications.

Sun Pharma's ILUMYA Receives FDA Review for Psoriatic Arthritis Treatment Expansion #USA #Princeton #ILUMYA #Sun_Pharma #Psoriatic_Arthritis

0 0 0 0
Preview
Sun Pharma Unveils New Findings on Dermatology and Immunology Products at Winter Clinical Miami 2026 At the 2026 Winter Clinical in Miami, Sun Pharma presents significant data across its dermatology and immunology offerings, showcasing innovations for patient care.

Sun Pharma Unveils New Findings on Dermatology and Immunology Products at Winter Clinical Miami 2026 #United_States #Aventura #ILUMYA #Sun_Pharma #Winlevi

0 0 0 0
Preview
Art Garfunkel Opens Up About Living with Psoriasis and Finding Hope Music legend Art Garfunkel candidly shares his journey with psoriasis, revealing his struggles and triumphs while advocating for better awareness.

Art Garfunkel Opens Up About Living with Psoriasis and Finding Hope #Psoriasis #ILUMYA #Art_Garfunkel

0 0 0 0
Preview
ILUMYA® Proves Effective in Treating Moderate-to-Severe Nail Psoriasis: Insights from AAD 2025 Conference Recent research showcases the effectiveness of ILUMYA® (tildrakizumab-asmn) in alleviating nail psoriasis symptoms in a significant patient cohort. The study highlights its promising results presented at the 2025 AAD Conference.

ILUMYA® Proves Effective in Treating Moderate-to-Severe Nail Psoriasis: Insights from AAD 2025 Conference #USA #Princeton #Psoriasis #ILUMYA #Sun_Pharma

0 0 0 0